Fig. 2
From: Triple blockade of Ido-1, PD-L1 and MEK as a potential therapeutic strategy in NSCLC
![Fig. 2](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12967-022-03730-y/MediaObjects/12967_2022_3730_Fig2_HTML.png)
Western blot analysis of Ido-1, PD-L1, MAPK, phospho-MAPK (pMAPK), MEK, phospho-MEK (pMEK), CTLA4, TIM3 and LAG3 on protein lysates from NSCLC cell lines A549, H460 and H1299. α-tubulin was included as a loading control. Control: untreated control, Mek-I: selumetinib, IFNγ: interferon-γ